Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A fetal lung maturity assessment is a critical test conducted to evaluate the development of a fetus's lungs prior to delivery. This assessment specifically utilizes the lecithin sphingomyelin (L/S) ratio, which is derived from an analysis of amniotic fluid. The primary purpose of this test is to assess lung maturity and to estimate the likelihood of the newborn developing respiratory distress syndrome (RDS), also known as hyaline membrane disease, after birth. The L/S ratio provides valuable information that can influence clinical decisions regarding the management of premature labor. If the test indicates that the fetal lungs are not yet mature, healthcare providers may consider interventions to suppress premature labor. Conversely, if the lungs are deemed mature enough, it may be appropriate to allow labor to progress or to induce labor in cases where the mother's or fetus's health is compromised. The assessment involves obtaining a sample of amniotic fluid, which is then analyzed to determine the L/S ratio. Lecithin, a component of pulmonary surfactant, increases in concentration as the fetus's lungs mature, while sphingomyelin, a non-pulmonary lipid, remains relatively stable in the amniotic fluid. The resulting L/S ratio is expressed numerically, with ratios greater than 2 indicating a lower risk of RDS, thereby guiding clinical decisions regarding delivery and neonatal care.
© Copyright 2026 Coding Ahead. All rights reserved.
The fetal lung maturity assessment using the lecithin sphingomyelin (L/S) ratio is indicated in several clinical scenarios, particularly when there is a concern regarding the maturity of the fetus's lungs. The following are the specific indications for performing this test:
The procedure for conducting a fetal lung maturity assessment via the lecithin sphingomyelin (L/S) ratio involves several key steps, each critical to obtaining accurate results:
After the fetal lung maturity assessment is completed, the results of the L/S ratio are typically communicated to the healthcare provider. Based on the findings, further clinical decisions can be made regarding the management of the pregnancy. If the L/S ratio indicates that the fetal lungs are mature (greater than 2), the healthcare team may proceed with plans for delivery. Conversely, if the ratio suggests immaturity, additional monitoring and potential interventions to delay delivery may be considered. It is also important to monitor the patient for any complications following the amniocentesis procedure, such as infection or premature rupture of membranes.
| Short Descr | L/S RATIO FETAL LUNG | Medium Descr | FETAL LUNG MATURITY LECITHIN SPHINGOMYELIN RATIO | Long Descr | Fetal lung maturity assessment; lecithin sphingomyelin (L/S) ratio | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 3 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 2001-01-01 | Changed | Code description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.